<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">smjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Спортивная медицина: наука и практика</journal-title><trans-title-group xml:lang="en"><trans-title>Sports medicine: research and practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2223-2524</issn><issn pub-type="epub">2587-9014</issn><publisher><publisher-name>NEICON</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47529/2223-2524.2023.4.1</article-id><article-id custom-type="elpub" pub-id-type="custom">smjournal-520</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФУНКЦИОНАЛЬНАЯ ДИАГНОСТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FUNCTIONAL TESTING</subject></subj-group></article-categories><title-group><article-title>Патология сердечно-сосудистой системы у лиц, возвращающихся к занятиям спортом после COVID-19</article-title><trans-title-group xml:lang="en"><trans-title>Pathology of the cardiovascular system in people returning to sports after COVID-19</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5378-7316</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шарыкин</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Sharykin</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шарыкин Александр Сергеевич, д.м.н., профессор кафедры госпитальной педиатрии; врач‑кардиолог; ведущий научный сотрудник</p><p>117997, г. Москва, ул. Островитянова, 1;</p><p>105120, г. Москва, улица Земляной вал, 53, стр 1;</p><p>121059, г. Москва, ул. Б. Дорогомиловская, 5</p></bio><bio xml:lang="en"><p>Alexander S. Sharykin, Dr. Sci. (Medicine), Professor of the Department of Hospital Pediatrics; cardiologist; Leading Researcher</p><p>117997, Moscow, Ostrovityanova str., 1;</p><p>105120, Moscow, Zemlyanoy Val str., 53, building 1;</p><p>121059, Moscow, Bolshaya Dorogomilovskaya str., 5</p></bio><email xlink:type="simple">sharykin1947@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4291-679X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бадтиева</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Badtieva</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бадтиева Виктория Асланбековна, д.м.н., член‑корреспондент РАН, заведующая филиалом №1; профессор кафедры восстановительной медицины, реабилитации и курортологии; ведущий научный сотрудник</p><p>105120, г. Москва, улица Земляной вал, 53, стр 1;</p><p>119991, г. Москва, ул. Трубецкая, 8, стр. 2.;</p><p>121059, г. Москва, ул. Большая Дорогомиловская, 5</p></bio><bio xml:lang="en"><p>Victoria A. Badtieva, Dr. Sci. (Medicine), Corresponding Member of the Russian Academy of Sciences, Head of Branch No. 1; Professor of the Department of Restorative Medicine, Rehabilitation and Balneology; Leading Researcher</p><p>105120, Moscow, Zemlyanoy Val str., 53, building 1;</p><p>119991, Moscow, ул. Trubetskaya str., 8, building 2;</p><p>121059, Moscow, Bolshaya Dorogomilovskaya str., 5</p></bio><email xlink:type="simple">vbadtieva@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0267-9761</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жолинский</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zholinsky</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жолинский Андрей Владимирович, к.м.н., директор</p><p>121059, Москва, Большая Дорогомиловская ул., 5</p></bio><bio xml:lang="en"><p>Andrey V. Zholinskiy, Cand. Sci. (Medicine), Director</p><p>121059, Moscow, Bolshaya Dorogomilovskaya str., 5</p></bio><email xlink:type="simple">zholinskiiAV@sportfmba.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2281-9936</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Парастаев</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Parastaev</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Парастаев Сергей Андреевич, д.м.н., профессор кафедры реабилитации, спортивной медицины и физической культуры; заместитель директора по научной работе</p><p>117513, Москва, ул. Островитянова, 1, стр. 6;</p><p>121059, Москва, ул. Большая Дорогомиловская, 5</p></bio><bio xml:lang="en"><p>Sergey A. Parastaev, Dr. Sci. (Medicine), Professor of the Department of Rehabilitation, Sports Medicine and Physical Culture; Deputy Director for Research</p><p>117997, Moscow, Ostrovityanova str., 1;</p><p>121059, Moscow, Bolshaya Dorogomilovskaya str., 5</p></bio><email xlink:type="simple">ParastaevSA@sportfmba.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1129-8271</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Усманов</surname><given-names>Д. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Usmanov</surname><given-names>D. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Усманов Дамир Мунирович, врач по спортивной медицине отдела медицинского обеспечения спортивных сборных команд и соревнований; аспирант</p><p>121059, Москва, ул. Большая Дорогомиловская ул., 5;</p><p>105120, г. Москва, ул. Земляной вал, 53</p></bio><bio xml:lang="en"><p>Damir M. Usmanov, sports medicine doctor of the Department of Medical Support for sports teams and competitions; postgraduate student</p><p>121059, Moscow, Bolshaya Dorogomilovskaya str., 5.;</p><p>105120, Moscow, Zemlyanoy Val str., 53, building 1</p></bio><email xlink:type="simple">damirmed@mail.ru</email><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГАУЗ «Московский научно-практический центр медицинской реабилитации, восстановительной и спортивной медицины Департамента здравоохранения г. Москвы»; ФГБУ «Федеральный научно-клинический центр спортивной медицины и реабилитации Федерального медико-биологического агентства»; ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Research and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine of Moscow Health Care Department; Federal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical and Biological Agency; Pirogov Russian National Research Medical University of Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГАУЗ «Московский научно-практический центр медицинской реабилитации, восстановительной и спортивной медицины Департамента здравоохранения г. Москвы»; ФГБУ «Федеральный научно-клинический центр спортивной медицины и реабилитации Федерального медико-биологического агентства»; ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Research and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine of Moscow Health Care Department; Federal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical and Biological Agency; Sechenov First Moscow State Medical University of Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ «Федеральный научно-клинический центр спортивной медицины и реабилитации Федерального медико-биологического агентства»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical and Biological Agency</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБУ «Федеральный научно-клинический центр спортивной медицины и реабилитации Федерального медико-биологического агентства»; &#13;
ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical and Biological Agency; Pirogov Russian National Research Medical University of Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ГАУЗ «Московский научно-практический центр медицинской реабилитации, восстановительной и спортивной медицины Департамента здравоохранения г. Москвы»; ФГБУ «Федеральный научно-клинический центр спортивной медицины и реабилитации Федерального медико-биологического агентства»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Research and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine of Moscow Health Care Department; Federal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical and Biological Agency</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>26</day><month>01</month><year>2024</year></pub-date><volume>13</volume><issue>4</issue><fpage>76</fpage><lpage>86</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шарыкин А.С., Бадтиева В.А., Жолинский А.В., Парастаев С.А., Усманов Д.М., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Шарыкин А.С., Бадтиева В.А., Жолинский А.В., Парастаев С.А., Усманов Д.М.</copyright-holder><copyright-holder xml:lang="en">Sharykin A.S., Badtieva V.A., Zholinsky A.V., Parastaev S.A., Usmanov D.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.smjournal.ru/jour/article/view/520">https://www.smjournal.ru/jour/article/view/520</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: обобщить опубликованные в нашей стране и за рубежом данные по диагностике кардиальных осложнений после COVID‑19 и сопоставить с собственным опытом обследования таких спортсменов.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: в качестве научной базы для достижения поставленной цели использовались открытые источники данных (ресурсы eLibrary, Scopus, PubMed и др.), проведен метаанализ 42 отечественных и зарубежных источников литературы по результатам постковидных изменений у спортсменов. Изучены также показатели 11 467 спортсменов в возрасте от 16 до 45 лет, выступающих за сборные команды Москвы и прошедших углубленное медицинское обследование на базе клиники спортивной медицины МНПЦ МРВСМ ДЗ г. Москвы.</p></sec><sec><title>Результаты</title><p>Результаты: распространенность миокардита при легком течении COVID‑19 у спортсменов не превышает 1 %, а аритмий — 9 %. Для их выявления в большинстве наблюдений достаточно классического сердечно‑сосудистого скрининга. В случаях, требующих госпитализации, риски повышаются: для миокардита — до 7,2 %, инфаркта миокарда — 4,7 %, других кардиальных осложнений — до 3–14 % и требуют расширенной диагностики. Для оптимального управления ресурсами в системе здравоохранения предложен рабочий алгоритм обследования спортсменов, возвращающихся к тренировкам после перенесенного COVID‑19.</p></sec><sec><title>Заключение</title><p>Заключение: при возвращении к занятиям спортом после COVID‑19 у симптомных лиц в большинстве случаев достаточно стандартного сердечно‑сосудистого скрининга. Однако для выявления возможной латентно протекающей патологии и оценки перспектив для спортсмена необходимы дополнительные обследования, включая нагрузочные тесты и МРТ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim: to summarize the data published in our country and abroad on the diagnosis of cardiac complications after COVID‑19 and to compare it with our own experience of examining such athletes.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: open data sources such as eLibrary, Scopus, PubMed etc. were used as a scientific base to achieve the set goal, a meta-analysis of 42 domestic and foreign literature sources was carried out upon the results of post‑COVID changes in athletes. Besides that, the indicators of 11467 athletes, aged from 16 to 45 years, were studied who have been playing for the Moscow national team and who passed in‑depth medical examination on the basis of Sports Medicine Clinic in Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine.</p></sec><sec><title>Results</title><p>Results: the prevalence of myocarditis in mild COVID‑19 in athletes does not exceed 1 %, arrhythmia does not exceed 9 %. Classical cardiovascular screening is sufficient for their detection in most cases. If hospitalization is necessary, the risks increase for myocarditis up to 7.2 %, for myocardial infarction up to 4,7 %, for other cardiac complications up to 3–14 % and require advanced diagnostics. For optimal resource management in the healthcare system, a working algorithm for examining athletes returning to trainings after a previous COVID‑19 is proposed.</p></sec><sec><title>Conclusion</title><p>Conclusion: in most cases a classical cardiovascular screening is enough for symptomatic individuals returning to sports trainings after the COVID‑19. However, additional examinations, including loading tests and MRT, are required to find out possible latent ongoing pathology as well to evaluate prospects for the athlete.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>спортсмены</kwd><kwd>постковидная патология</kwd><kwd>осложнения сердечно‑сосудистой системы</kwd><kwd>допуск к тренировкам</kwd></kwd-group><kwd-group xml:lang="en"><kwd>athletes</kwd><kwd>post‑COVID pathology</kwd><kwd>cardiovascular system complications</kwd><kwd>access to trainings</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">COVID-19 Cumulative Infection Collaborators. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet. 2022;399(10344):2351–2380. https://doi.org/10.1016/S0140-6736(22)00484-6</mixed-citation><mixed-citation xml:lang="en">COVID-19 Cumulative Infection Collaborators. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet. 2022;399(10344):2351–2380. https://doi.org/10.1016/S0140-6736(22)00484-6</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Udelson J.E., Rowin E.J., Maron B.J. Return to Play for Athletes After COVID-19 Infection: The Fog Begins to Clear. JAMA Cardiol. 2021;6(9):997–999. https://doi.org/10.1001/jamacar-dio.2021.2079</mixed-citation><mixed-citation xml:lang="en">Udelson J.E., Rowin E.J., Maron B.J. Return to Play for Athletes After COVID-19 Infection: The Fog Begins to Clear. JAMA Cardiol. 2021;6(9):997–999. https://doi.org/10.1001/jamacar-dio.2021.2079</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Romagnoli S., Sbrollini A., Marcantoni I., Morettini M., Burattini L. Review on Cardiorespiratory Complications after SARS-CoV-2 Infection in Young Adult Healthy Athletes. Int J Environ Res Public Health. 2022;19(9):5680. https://doi.org/10.3390/ijerph19095680</mixed-citation><mixed-citation xml:lang="en">Romagnoli S., Sbrollini A., Marcantoni I., Morettini M., Burattini L. Review on Cardiorespiratory Complications after SARS-CoV-2 Infection in Young Adult Healthy Athletes. Int J Environ Res Public Health. 2022;19(9):5680. https://doi.org/10.3390/ijerph19095680</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at: https://www.covid19treatmentguidelines.nih.gov/.</mixed-citation><mixed-citation xml:lang="en">COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at: https://www.covid19treatmentguidelines.nih.gov/.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Elseidy S.A., Awad A.K., Vorla M., Fatima A., Elbadawy M.A., Mandal D., Mohamad T. Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS). Int. J. Cardiol. Heart Vasc. 2022;40:101012. https://doi.org/10.1016/j.ijcha.2022.101012</mixed-citation><mixed-citation xml:lang="en">Elseidy S.A., Awad A.K., Vorla M., Fatima A., Elbadawy M.A., Mandal D., Mohamad T. Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS). Int. J. Cardiol. Heart Vasc. 2022;40:101012. https://doi.org/10.1016/j.ijcha.2022.101012</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fritsche L.G., Jin W., Admon A.J., Mukherjee B. Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 Infection (PASC) in a Large Academic Medical Center in the US. J. Clin. Med. 2023;12(4):1328. https://doi.org/10.3390/jcm12041328</mixed-citation><mixed-citation xml:lang="en">Fritsche L.G., Jin W., Admon A.J., Mukherjee B. Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 Infection (PASC) in a Large Academic Medical Center in the US. J. Clin. Med. 2023;12(4):1328. https://doi.org/10.3390/jcm12041328</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">O’Brien K.K., Brown D.A., McDuff K., St Clair-Sullivan N., Solomon P., Chan Carusone S., et al. Conceptualising the episodic nature of disability among adults living with Long COVID: a qualitative study. BMJ Glob. Health. 2023;8(3):e011276. https://doi.org/10.1136/bmjgh-2022-011276</mixed-citation><mixed-citation xml:lang="en">O’Brien K.K., Brown D.A., McDuff K., St Clair-Sullivan N., Solomon P., Chan Carusone S., et al. Conceptualising the episodic nature of disability among adults living with Long COVID: a qualitative study. BMJ Glob. Health. 2023;8(3):e011276. https://doi.org/10.1136/bmjgh-2022-011276</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Van Doremalen N., Bushmaker T., Morris D., Holbrook M.G., Gamble A., Williamson B.N., et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 2020;382(16):1564–1567. https://doi.org/10.1056/NEJMc2004973</mixed-citation><mixed-citation xml:lang="en">Van Doremalen N., Bushmaker T., Morris D., Holbrook M.G., Gamble A., Williamson B.N., et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 2020;382(16):1564–1567. https://doi.org/10.1056/NEJMc2004973</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Writing Committee; Gluckman T.J., Bhave N.M., Allen L.A., Chung E.H., Spatz E.S., Ammirati E., et al. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 2022;79(17):1717–1756. https://doi.org/10.1016/j.jacc.2022.02.003</mixed-citation><mixed-citation xml:lang="en">Writing Committee; Gluckman T.J., Bhave N.M., Allen L.A., Chung E.H., Spatz E.S., Ammirati E., et al. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 2022;79(17):1717–1756. https://doi.org/10.1016/j.jacc.2022.02.003</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Методические рекомендации «Особенности течения Long-COVID-инфекции. Терапевтические и реабилитационные мероприятия». Терапия. 2022;1 (Приложение):1–147. https://doi.org/10.18565/therapy.2022.1suppl.1-147</mixed-citation><mixed-citation xml:lang="en">Guidelines “Peculiarities of the course of Long-COVID infection. Therapeutic and rehabilitation measures. Therapy. 2022;1 (Appendix):1–147. (In Russ.). https://doi.org/10.18565/therapy.2022.1suppl.1-147</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Navaratnarajah C.K., Pease D.R., Halfmann P.J., Taye B., Barkhymer A., Howell K.G., et al. Wanek Family Program for HLHS-Stem Cell Pipeline. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition. J. Virol. 2021;95(24):e0136821. https://doi.org/10.1128/JVI.01368-21</mixed-citation><mixed-citation xml:lang="en">Navaratnarajah C.K., Pease D.R., Halfmann P.J., Taye B., Barkhymer A., Howell K.G., et al. Wanek Family Program for HLHS-Stem Cell Pipeline. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition. J. Virol. 2021;95(24):e0136821. https://doi.org/10.1128/JVI.01368-21</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chang X., Ismail N.I., Rahman A., Xu D., Chan R.W.Y., Ong S.G., Ong S.B. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link? Antioxid Redox Signal. 2023;38(7-9):599–618. https://doi.org/10.1089/ars.2022.0126</mixed-citation><mixed-citation xml:lang="en">Chang X., Ismail N.I., Rahman A., Xu D., Chan R.W.Y., Ong S.G., Ong S.B. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link? Antioxid Redox Signal. 2023;38(7-9):599–618. https://doi.org/10.1089/ars.2022.0126</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dores H., Cardim N. Return to play after COVID-19: a sport cardiologist’s view. Br. J. Sports Med. 2020;54(19):1132–1133. https://doi.org/10.1136/bjsports-2020-102482</mixed-citation><mixed-citation xml:lang="en">Dores H., Cardim N. Return to play after COVID-19: a sport cardiologist’s view. Br. J. Sports Med. 2020;54(19):1132–1133. https://doi.org/10.1136/bjsports-2020-102482</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">van Hattum J.C., Spies J.L., Verwijs S.M., Verwoert G.C., Planken R.N., Boekholdt S.M., et al. Cardiac abnormalities in athletes after SARS-CoV-2 infection: a systematic review. BMJ Open Sport Exerc. Med. 2021;7(4):e001164. https://doi.org/10.1136/bmjsem-2021-001164</mixed-citation><mixed-citation xml:lang="en">van Hattum J.C., Spies J.L., Verwijs S.M., Verwoert G.C., Planken R.N., Boekholdt S.M., et al. Cardiac abnormalities in athletes after SARS-CoV-2 infection: a systematic review. BMJ Open Sport Exerc. Med. 2021;7(4):e001164. https://doi.org/10.1136/bmjsem-2021-001164</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cavigli L., Cillis M., Mochi V., Frascaro F., Mochi N., Hajdarevic A., et al. SARS-CoV-2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed? Br. J. Sports Med. 2022;56(5):264–270. https://doi.org/10.1136/bjs-ports-2021-104764</mixed-citation><mixed-citation xml:lang="en">Cavigli L., Cillis M., Mochi V., Frascaro F., Mochi N., Hajdarevic A., et al. SARS-CoV-2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed? Br. J. Sports Med. 2022;56(5):264–270. https://doi.org/10.1136/bjs-ports-2021-104764</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Halushka M.K., Vander Heide R.S. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc. Pathol. 2021;50:107300. https://doi.org/10.1016/j.carpath.2020.107300</mixed-citation><mixed-citation xml:lang="en">Halushka M.K., Vander Heide R.S. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc. Pathol. 2021;50:107300. https://doi.org/10.1016/j.carpath.2020.107300</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Harris K.M., Mackey-Bojack S., Bennett M., Nwaudo D., Duncanson E., Maron B.J. Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes. Am. J. Cardiol. 2021;143:131–134. https://doi.org/10.1016/j.amjcard.2020.12.028</mixed-citation><mixed-citation xml:lang="en">Harris K.M., Mackey-Bojack S., Bennett M., Nwaudo D., Duncanson E., Maron B.J. Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes. Am. J. Cardiol. 2021;143:131–134. https://doi.org/10.1016/j.amjcard.2020.12.028</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Daniels C.J., Rajpal S., Greenshields J.T., Rosenthal G.L., Chung E. H., Terrin M., et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection results from the big ten COVID-19 cardiac registry. JAMA Cardiology. 2021;6(9):1078–1087. https://doi.org/10.1001/jamacar-dio.2021.2065</mixed-citation><mixed-citation xml:lang="en">Daniels C.J., Rajpal S., Greenshields J.T., Rosenthal G.L., Chung E. H., Terrin M., et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection results from the big ten COVID-19 cardiac registry. JAMA Cardiology. 2021;6(9):1078–1087. https://doi.org/10.1001/jamacar-dio.2021.2065</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kochi A.N., Tagliari A.P., Forleo G.B., Fassini G.M., Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J. Cardiovasc. Electrophysiol. 2020;31(5):1003–1008. https://doi.org/10.1111/jce.14479</mixed-citation><mixed-citation xml:lang="en">Kochi A.N., Tagliari A.P., Forleo G.B., Fassini G.M., Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J. Cardiovasc. Electrophysiol. 2020;31(5):1003–1008. https://doi.org/10.1111/jce.14479</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Maestrini V., Penza M., Filomena D., Birtolo L.I., Monosilio S., Lemme E., et al. Low prevalence of cardiac abnormalities in competitive athletes at return-to-play after COVID-19. J. Sci. Med. Sport. 2023; 26(1):8–13. https://doi.org/10.1016/j.jsams.2022.10.015</mixed-citation><mixed-citation xml:lang="en">Maestrini V., Penza M., Filomena D., Birtolo L.I., Monosilio S., Lemme E., et al. Low prevalence of cardiac abnormalities in competitive athletes at return-to-play after COVID-19. J. Sci. Med. Sport. 2023; 26(1):8–13. https://doi.org/10.1016/j.jsams.2022.10.015</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Clemens D.J., Ye D., Zhou W., Kim C.S.J., Pease D.R., Navaratnarajah C.K., et al. SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19. PLoS One. 2023;18(3):e0282151. https://doi.org/10.1371/journal.pone.0282151</mixed-citation><mixed-citation xml:lang="en">Clemens D.J., Ye D., Zhou W., Kim C.S.J., Pease D.R., Navaratnarajah C.K., et al. SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19. PLoS One. 2023;18(3):e0282151. https://doi.org/10.1371/journal.pone.0282151</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Groen R.A., de Graaf M.A., Stöger J.L., van Dijkman P.R.M., Jukema J.W., Schalij M.J., Geelhoed J.J.M., Antoni M.L. Coronary calcium score in COVID-19 survivors: Association with cardiac injury and cardiac function after 6 weeks. Am. Heart J. Plus. 2023;27:100280. https://doi.org/10.1016/j.ahjo.2023.100280</mixed-citation><mixed-citation xml:lang="en">Groen R.A., de Graaf M.A., Stöger J.L., van Dijkman P.R.M., Jukema J.W., Schalij M.J., Geelhoed J.J.M., Antoni M.L. Coronary calcium score in COVID-19 survivors: Association with cardiac injury and cardiac function after 6 weeks. Am. Heart J. Plus. 2023;27:100280. https://doi.org/10.1016/j.ahjo.2023.100280</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Воробьев П.А., ред. Рекомендации по ведению больных с коронавирусной инфекцией COVID-19 в острой фазе и при постковидном синдроме в амбулаторных условиях. Available at: https://guidelines.mgnot.ru/v2_2021 (accessed 04 January 2023)]</mixed-citation><mixed-citation xml:lang="en">Vorobiev P.A., ed. Recommendations for the management of patients with coronavirus infection COVID-19 in the acute phase and with post-COVID syndrome on an outpatient basis. (in Russ.). Available at: https://guidelines.mgnot.ru/v2_2021 (accessed 04 January 2023)]</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41(11):1783–1790. https://doi.org/10.1016/j.vaccine.2023.02.008</mixed-citation><mixed-citation xml:lang="en">Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41(11):1783–1790. https://doi.org/10.1016/j.vaccine.2023.02.008</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lane S., Yeomans A., Shakir S. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature. BMJ Open. 2022;12(5):e059223. https://doi.org/10.1136/bmjopen-2021-059223; Erratum: BMJ Open. 2022;12(7):e059223corr1</mixed-citation><mixed-citation xml:lang="en">Lane S., Yeomans A., Shakir S. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature. BMJ Open. 2022;12(5):e059223. https://doi.org/10.1136/bmjopen-2021-059223; Erratum: BMJ Open. 2022;12(7):e059223corr1</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 2022;28(2):410–422. https://doi.org/10.1038/s41591-021-01630-0</mixed-citation><mixed-citation xml:lang="en">Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 2022;28(2):410–422. https://doi.org/10.1038/s41591-021-01630-0</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Gröschel J., Bhoyroo Y., Blaszczyk E., Trauzeddel R.F., Viezzer D., Saad H., Fenski M., Schulz-Menger J. Different Impacts on the Heart After COVID-19 Infection and Vaccination: Insights From Cardiovascular Magnetic Resonance. Front. Cardiovasc. Med. 2022;9:916922. https://doi.org/10.3389/fcvm.2022.916922</mixed-citation><mixed-citation xml:lang="en">Gröschel J., Bhoyroo Y., Blaszczyk E., Trauzeddel R.F., Viezzer D., Saad H., Fenski M., Schulz-Menger J. Different Impacts on the Heart After COVID-19 Infection and Vaccination: Insights From Cardiovascular Magnetic Resonance. Front. Cardiovasc. Med. 2022;9:916922. https://doi.org/10.3389/fcvm.2022.916922</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Mustafa Alhussein M., Rabbani M., Sarak B., Dykstra S., Labib D., Flewitt J., et al. Natural History of Myocardial Injury After COVID-19 Vaccine-Associated Myocarditis. Can. J. Cardiol. 2022;38(11):1676–1683. https://doi.org/10.1016/j.cjca.2022.07.017</mixed-citation><mixed-citation xml:lang="en">Mustafa Alhussein M., Rabbani M., Sarak B., Dykstra S., Labib D., Flewitt J., et al. Natural History of Myocardial Injury After COVID-19 Vaccine-Associated Myocarditis. Can. J. Cardiol. 2022;38(11):1676–1683. https://doi.org/10.1016/j.cjca.2022.07.017</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Blomberg B., Mohn K.G., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., et al.; Bergen COVID-19 Research Group; Cox R.J., Langeland N. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27(9):1607-1613. https://doi.org/10.1038/s41591-021-01433-3</mixed-citation><mixed-citation xml:lang="en">Blomberg B., Mohn K.G., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., et al.; Bergen COVID-19 Research Group; Cox R.J., Langeland N. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27(9):1607-1613. https://doi.org/10.1038/s41591-021-01433-3</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Śliż D., Wiecha S., Ulaszewska K., Gąsior J.S., Lewandowski M., Kasiak P.S., Mamcarz A. COVID-19 and athletes: Endurance sport and activity resilience study-CAESAR study. Front. Physiol. 2022;13:1078763. https://doi.org/10.3389/fphys.2022.1078763</mixed-citation><mixed-citation xml:lang="en">Śliż D., Wiecha S., Ulaszewska K., Gąsior J.S., Lewandowski M., Kasiak P.S., Mamcarz A. COVID-19 and athletes: Endurance sport and activity resilience study-CAESAR study. Front. Physiol. 2022;13:1078763. https://doi.org/10.3389/fphys.2022.1078763</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Поляев Б.А., Шляхто Е.В., ред. Пособие по критериям допуска совершеннолетних лиц к занятиям спортом в соответствии с видом спорта, полом и возрастом при заболеваниях, патологических состояниях и отклонениях со стороны сердечно-сосудистой системы. Москва; Рязань: ГУП РО «Рязанская областная типография»; 2022.</mixed-citation><mixed-citation xml:lang="en">Polyaev B.A., Shlyakhto E.V., eds. A manual on the criteria for admission of adults to sports in accordance with the type of sport, gender and age for diseases, pathological conditions and deviations from the cardiovascular system. Moscow; Ryazan: GUP RO “Ryazan Regional Printing House”; 2022. (In Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
